MAPT and Alzheimer disease: By using IMR assays for plasma Aβ1–40, Aβ1–42, T-Tau, α-synuclein and TDP-43 in NC, the AD family, the PD family and FTD, the dominant roles of these biomarkers in these neurodegenerative diseases were clarified.